Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.98Price to Sales
VS
Market
Sector
Industry
History
$ 1.5Close
$ 0.89 - $ 3.14 52-Week Range
Ticker Information
Ticker
TELACompany Name
TELA BIO INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQTELA BIO INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TELA - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 73.69M | 0.98 | $ 75.32M |
| 3/31/2025 | $ 39.2M | 0.55 | $ 71.22M |
| 12/31/2024 | $ 58.14M | 0.84 | $ 69.3M |
| 9/30/2024 | $ 121.12M | 1.76 | $ 68.65M |
| 6/30/2024 | $ 76.37M | 1.18 | $ 64.74M |
| 3/31/2024 | $ 142.26M | 2.25 | $ 63.15M |
| 12/31/2023 | $ 141.24M | 2.42 | $ 58.45M |
| 9/30/2023 | $ 110.2M | 2.08 | $ 53.08M |
| 6/30/2023 | $ 214.75M | 4.37 | $ 49.18M |
| 3/31/2023 | $ 243.49M | 5.4 | $ 45.1M |
Key Performance Insights, Last 5 Years
- TELA BIO INC's latest trailing twelve months (TTM) P/S stands at 13.6.
- Over the past 5 years, TELA BIO INC's average P/S has been 4.58.
- The median P/S for TELA BIO INC during this period was 4
- TELA BIO INC reached its highest P/S over the past 5 years at 13.6.
- The lowest P/S recorded by TELA BIO INC in the same timeframe 0.55
TELA BIO INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for TELA BIO INC is calculated as follows: Market Cap [ $ 236.83M ] / Revenues [ $ 17.41M ]
(=) P/S [ 13.6 ] TELA - Price to Sales, Last 5 years
0.55
Minimum
Mar 31, 2025
13.6
Maximum
Sep 30, 2020
4.58
Average
4
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |